
	Three months ended March 31,
	2025		2024
	(in thousands except per share amounts)

Numerator:
Net income (loss) from continuing operations	$	934	$	(16,010)
Loss from discontinued operations, net of income tax	(8,647)		(314)
Net loss attributable to common stockholders	$	(7,713)	$	(16,324)

Denominator:
Weighted-average shares of common stock outstanding, basic	183,468		186,635
Weighted-average shares of common stock outstanding, diluted	185,222		186,635

Net income (loss) per share attributable to common stockholders, basic:
Continuing operations	$	0.01	$	(0.09)
Discontinued operations	(0.05)		—
Net loss per share	$	(0.04)	$	(0.09)


Net income (loss) per share attributable to common stockholders, diluted:
Continuing operations	$	0.01	$	(0.09)
Discontinued operations	(0.05)		—
Net loss per share	$	(0.04)	$	(0.09)

The following table illustrates the reconciliation of the denominators of the basic and diluted EPS computations for income (loss) from continuing operations and loss from discontinued operations, net of income tax.


	Three months ended March 31,
	2025	2024
	(in thousands)
Weighted-average shares of common stock outstanding, basic	183,468	186,635
Shares of common stock subject to outstanding RSUs	470	—
Shares of common stock subject to outstanding options	1,077	—
Shares of common stock pursuant to ESPP	207	—
Weighted-average shares of common stock outstanding, diluted	185,222	186,635

The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect as of:


	March 31,
	2025	2024
	(in thousands)
Outstanding stock options and unvested RSUs	19,612	18,330
Shares of common stock pursuant to ESPP	—	227
Total anti-dilutive outstanding potential common stock	19,612	18,557